1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1h-imidazole has been researched along with Pneumonia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arredouani, A; Azizi, F; Chikri, M; Dermime, S; Janahi, IA; Merhi, M; Mohammad, RM; Parray, AS; Prabhu, KS; Siveen, KS; Steinhoff, M; Uddin, S | 1 |
1 other study(ies) available for 1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1h-imidazole and Pneumonia
Article | Year |
---|---|
Evaluation of cationic channel TRPV2 as a novel biomarker and therapeutic target in Leukemia-Implications concerning the resolution of pulmonary inflammation.
Topics: ADP-ribosyl Cyclase 1; Apoptosis; Biomarkers; Calcium; Cell Cycle Checkpoints; Cell Line, Tumor; Down-Regulation; Humans; Imidazoles; Leukemia; Leukocytes, Mononuclear; Mitogen-Activated Protein Kinases; ortho-Aminobenzoates; Pneumonia; Protein Isoforms; RNA Interference; RNA, Small Interfering; Signal Transduction; TRPV Cation Channels; Up-Regulation | 2019 |